FC(F)(F)c1ccc(Cl)c(-n2c(S)nnc2-c2cc(C3CC3)[nH]n2)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?